Chen J, Woodward D F
Allergan, Inc., Irvine, CA 92713-9534.
Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3195-201.
The pharmacology of prostanoid-induced relaxation of the precontracted cat ciliary smooth muscle was characterized using synthetic prostaglandin (PG) analogues that are selective for specific prostanoid receptors. Relaxation was studied using carbachol to precontract the isolated longitudinal ciliary muscle, followed by application of the PG agonist. Of the compounds studied, PGE2 was the most potent relaxant (concentration that produced 50% of maximum relaxation, 10(-7) mol/l), and its maximal effect in each preparation was used as a standard for comparison. Both PGD2 and PGF2 alpha produced relaxations that were approximately 30- and 100-fold weaker, respectively, than those produced by PGE2. Prostanoids with activity at the EP2 (19-(R)-hydroxy PGE2 and 11-deoxy PGE1) and DP (BW 245C) receptors potently relaxed the ciliary muscle. Other EP receptor subtypes and the TP receptor were not involved as indicated by the lack of relaxant activity of sulprostone (EP3 > EP1), MB 28767 (EP3 > TP), and U-46619 (TP). Although 17-phenyl trinor PGE2 (EP1 and EP3) and PGI2 (IP) had some activity, it occurred at a nonselective dose (10(-4) mol/l). The presence of DP receptors in the cat ciliary muscle was confirmed by using BW A868C, a selective DP-receptor antagonist. This drug (concentration, 1 mumol/l) displaced the relaxant effects of PGD2 but had no effect on the activities of PGE2 and 11-deoxy PGE1. In addition, 17-phenyl trinor PGF2 alpha (FP) was inactive, indicating that the FP receptor was not involved in ciliary muscle relaxation.(ABSTRACT TRUNCATED AT 250 WORDS)
利用对特定前列腺素受体具有选择性的合成前列腺素(PG)类似物,对前列腺素诱导的预收缩猫睫状平滑肌舒张的药理学特性进行了研究。使用卡巴胆碱使分离的纵向睫状肌预收缩,然后应用PG激动剂来研究舒张情况。在所研究的化合物中,PGE2是最有效的舒张剂(产生最大舒张50%的浓度为10^(-7) mol/l),其在每种制剂中的最大效应被用作比较标准。PGD2和PGF2α产生的舒张作用分别比PGE2产生的弱约30倍和100倍。对EP2(19-(R)-羟基PGE2和11-脱氧PGE1)和DP(BW 245C)受体有活性的前列腺素能有效地舒张睫状肌。如舒前列素(EP3>EP1)、MB 28767(EP3>TP)和U-46619(TP)缺乏舒张活性所示,其他EP受体亚型和TP受体未参与其中。尽管17-苯基三降PGE2(EP1和EP3)和PGI2(IP)有一些活性,但它是在非选择性剂量(10^(-4) mol/l)下出现的。使用选择性DP受体拮抗剂BW A868C证实了猫睫状肌中存在DP受体。该药物(浓度为1 μmol/l)可消除PGD2的舒张作用,但对PGE2和11-脱氧PGE1的活性无影响。此外,17-苯基三降PGF2α(FP)无活性,表明FP受体不参与睫状肌舒张。(摘要截短于250字)